Frank Takkinen
Stock Analyst at Lake Street
(1.17)
# 3,744
Out of 5,048 analysts
65
Total ratings
33.9%
Success rate
-11.39%
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LUNG Pulmonx | Maintains: Buy | $8 → $4 | $1.83 | +118.58% | 3 | Oct 28, 2025 | |
| SGHT Sight Sciences | Maintains: Buy | $5 → $7 | $5.10 | +37.25% | 6 | Oct 21, 2025 | |
| RCEL AVITA Medical | Downgrades: Hold | $8 → $4 | $3.78 | +5.82% | 1 | Oct 17, 2025 | |
| ELUT Elutia | Maintains: Buy | $8 → $6 | $0.94 | +541.57% | 4 | Sep 10, 2025 | |
| HYPR Hyperfine | Maintains: Buy | $1.5 → $2 | $1.13 | +76.99% | 2 | Aug 14, 2025 | |
| INSP Inspire Medical Systems | Maintains: Buy | $270 → $150 | $73.71 | +103.50% | 2 | Aug 5, 2025 | |
| ANGO AngioDynamics | Initiates: Buy | $24 | $11.83 | +102.87% | 1 | Jul 16, 2025 | |
| BBNX Beta Bionics | Assumes: Buy | $30 | $27.71 | +8.28% | 1 | Jun 12, 2025 | |
| NOTV Inotiv | Maintains: Buy | $6 → $5 | $1.24 | +303.23% | 7 | May 8, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $19 → $14 | $10.36 | +35.14% | 7 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $16 → $15 | $12.50 | +20.00% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $23.25 | +29.03% | 1 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $26 | $16.62 | +56.44% | 3 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $30 | $19.00 | +57.89% | 4 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $5 | $3.84 | +30.21% | 2 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $4.35 | +359.77% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.29 | +118.34% | 1 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $1.37 | +483.94% | 2 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $30 | $45.69 | -34.34% | 2 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $6 | $0.76 | +685.65% | 2 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $2.78 | +43.88% | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $9.40 | +27.66% | 2 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $3.20 | +181.25% | 3 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $16 | $2.02 | +692.08% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $9.23 | $0.40 | +2,207.50% | 2 | Jan 18, 2023 |
Pulmonx
Oct 28, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.83
Upside: +118.58%
Sight Sciences
Oct 21, 2025
Maintains: Buy
Price Target: $5 → $7
Current: $5.10
Upside: +37.25%
AVITA Medical
Oct 17, 2025
Downgrades: Hold
Price Target: $8 → $4
Current: $3.78
Upside: +5.82%
Elutia
Sep 10, 2025
Maintains: Buy
Price Target: $8 → $6
Current: $0.94
Upside: +541.57%
Hyperfine
Aug 14, 2025
Maintains: Buy
Price Target: $1.5 → $2
Current: $1.13
Upside: +76.99%
Inspire Medical Systems
Aug 5, 2025
Maintains: Buy
Price Target: $270 → $150
Current: $73.71
Upside: +103.50%
AngioDynamics
Jul 16, 2025
Initiates: Buy
Price Target: $24
Current: $11.83
Upside: +102.87%
Beta Bionics
Jun 12, 2025
Assumes: Buy
Price Target: $30
Current: $27.71
Upside: +8.28%
Inotiv
May 8, 2025
Maintains: Buy
Price Target: $6 → $5
Current: $1.24
Upside: +303.23%
CVRx, Inc.
Apr 8, 2025
Maintains: Buy
Price Target: $19 → $14
Current: $10.36
Upside: +35.14%
Mar 24, 2025
Downgrades: Hold
Price Target: $16 → $15
Current: $12.50
Upside: +20.00%
Mar 17, 2025
Initiates: Buy
Price Target: $30
Current: $23.25
Upside: +29.03%
Feb 14, 2025
Maintains: Buy
Price Target: $17 → $26
Current: $16.62
Upside: +56.44%
Jan 21, 2025
Maintains: Buy
Price Target: $17 → $30
Current: $19.00
Upside: +57.89%
Jan 14, 2025
Maintains: Buy
Price Target: $4 → $5
Current: $3.84
Upside: +30.21%
Jan 8, 2025
Initiates: Buy
Price Target: $20
Current: $4.35
Upside: +359.77%
Dec 11, 2024
Initiates: Buy
Price Target: $5
Current: $2.29
Upside: +118.34%
Aug 13, 2024
Maintains: Buy
Price Target: $14 → $8
Current: $1.37
Upside: +483.94%
Jul 2, 2024
Maintains: Buy
Price Target: $28 → $30
Current: $45.69
Upside: -34.34%
Apr 3, 2024
Maintains: Buy
Price Target: $3 → $6
Current: $0.76
Upside: +685.65%
Mar 5, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $2.78
Upside: +43.88%
Dec 27, 2023
Reiterates: Buy
Price Target: $12
Current: $9.40
Upside: +27.66%
Jun 15, 2023
Maintains: Buy
Price Target: $6 → $9
Current: $3.20
Upside: +181.25%
May 18, 2023
Maintains: Buy
Price Target: $14 → $16
Current: $2.02
Upside: +692.08%
Jan 18, 2023
Maintains: Buy
Price Target: $31 → $9.23
Current: $0.40
Upside: +2,207.50%